Keyser Brian M, Leverette Robert, McRae Reagan, Wertman John, Shutsky Tom, Szeliga Ken, Makena Patrudu, Jordan Kristen G
RAI Services Company, Winston-Salem, NC, United States.
Front Toxicol. 2024 Nov 28;6:1452274. doi: 10.3389/ftox.2024.1452274. eCollection 2024.
Modern oral nicotine pouch products (ONPs) are a category of oral nicotine products which contain pharmaceutical-grade nicotine, flavors, and other food-grade ingredients but no tobacco leaf. Recent reports indicate that ONPs in general do not contain (or only at minimal levels) the harmful and potentially harmful constituents (HPHCs) identified in cigarette smoke, suggesting their potential as alternative products for reducing harm from cigarette smoking.
We assessed toxicological effects of eight ONPs, designated as modern oral (MO) 1 to 8 along with an ONP, an oral tobacco (snus), and a combustible cigarette market comparator using established regulatory toxicological assays including Ames, micronucleus (ivMN), and neutral red uptake (NRU) assays.
The MO test products 1-7 ZYN wintergreen, and General Snus white mint were negative for mutagenicity (Ames assay), genotoxicity (ivMN), and cytotoxicity (NRU). The combustible cigarette was positive in all three assays. The MO-8 test product was negative for mutagenicity; however, it was positive in the ivMN and NRU assays at concentrations either 42 to 135-fold based on the ivMN i to iv treatment schedule or 60-fold higher, respectively, when compared to combustible cigarettes.
Thus, the MO test products are likely to be less harmful than combustible cigarettes and are alternatives to cigarettes. However, understanding of long-term effects of ONPs in general requires additional research.
现代口腔尼古丁袋产品(ONPs)是一类口腔尼古丁产品,含有药用级尼古丁、香料和其他食品级成分,但不含烟叶。最近的报告表明,一般来说,ONPs不含有(或仅含有极少量)香烟烟雾中确定的有害和潜在有害成分(HPHCs),这表明它们有可能作为减少吸烟危害的替代产品。
我们使用包括艾姆斯试验、微核试验(ivMN)和中性红摄取试验(NRU)等既定的监管毒理学试验,评估了8种ONPs的毒理学效应,这些产品被指定为现代口腔(MO)1至8,同时还有一种ONP、一种口含烟草(鼻烟)和一种可燃香烟作为市场对照品。
MO测试产品1 - 7(悦刻冬青木香型和通用白薄荷味鼻烟)在致突变性(艾姆斯试验)、遗传毒性(ivMN)和细胞毒性(NRU)方面呈阴性。可燃香烟在所有三项试验中均呈阳性。MO - 8测试产品在致突变性方面呈阴性;然而,与可燃香烟相比,根据ivMN的i至iv治疗方案,其在ivMN和NRU试验中的浓度分别高出42至135倍或60倍时呈阳性。
因此,MO测试产品可能比可燃香烟危害更小,是香烟的替代品。然而,总体而言,对ONPs长期影响的了解还需要更多研究。